Hypertensive Emergency: Parenteral Antihypertensives and Population Data.
HMOD
Hypertension
Hypertensive emergency
Organ damage
Parenteral therapy
Journal
Current hypertension reports
ISSN: 1534-3111
Titre abrégé: Curr Hypertens Rep
Pays: United States
ID NLM: 100888982
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
accepted:
25
10
2023
medline:
6
12
2023
pubmed:
17
11
2023
entrez:
17
11
2023
Statut:
ppublish
Résumé
Review parenteral therapeutic choices in treatment of hypertensive crises by mechanism of action and summarize recent literature on the management of hypertensive crises. Recent data have documented the safety and efficacy of labetalol and nicardipine in treatment of hypertensive crises as well as characterized the hypertensive emergency population to a much greater extent. Based on recent data, hypertensive emergencies are seen in 0.5% of all emergency room visits. Ischemic stroke and heart failure/pulmonary edema are the most common forms of organ damage seen in hypertensive emergencies. There are many therapeutic choices in treatment of hypertensive crises with varied mechanisms of action. Large randomized, controlled trial evidence is lacking in this therapeutic area; however, recent data have documented the safety and efficacy of labetalol and nicardipine.
Identifiants
pubmed: 37975973
doi: 10.1007/s11906-023-01280-2
pii: 10.1007/s11906-023-01280-2
doi:
Substances chimiques
Antihypertensive Agents
0
Nicardipine
CZ5312222S
Labetalol
R5H8897N95
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
423-428Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.